Filter Set, PMF 2028
510(k) K760639
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK760639 | Date15 Oct 1976 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KOC
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
This device is a filter set accessory for hemodialysis blood circuits, as defined in the device name and specifications. It is classified as a Class II medical device under regulation number 876.5820 and product code KOC.
The device received traditional 510(k) clearance (K760639) from the FDA on October 15, 1976, and is substantially equivalent to a predicate device. It was reviewed by the Gastroenterology and Urology advisory committee and is manufactured by Sorensen Research in McHenry, Illinois.
Other devices from Sorensen Research
Questions
AI-generated answers, 27 Sep 2026
What is the FILTER SET PMF 2028 used for?
The FILTER SET PMF 2028 is an accessory designed for use in hemodialysis blood circuits, as specified in its device name and intended to support the filtration function within extracorporeal blood flow systems during dialysis treatment.
How is the FILTER SET PMF 2028 supplied or packaged?
The device data does not specify packaging details, sterilization state, or whether the FILTER SET PMF 2028 is single-use or reusable; therefore, no information on its supply format can be derived from the provided authorization records.
What regulatory pathway was used for the FILTER SET PMF 2028?
The FILTER SET PMF 2028 received traditional 510(k) clearance (K760639) from the FDA on October 15, 1976, based on a determination of substantial equivalence to a predicate device, following review by the Gastroenterology and Urology advisory committee.